Engrail Therapeutics Inc

This study tested an experimental drug called ENX-102 in 47 adults with social anxiety disorder. Participants received either the drug or a placebo to see if it reduced fear and avoidance in social situations. The goal was to measure changes in anxiety symptoms using a standard q…

This study tested an experimental drug called ENX-102 in 252 adults with generalized anxiety disorder. The goal was to see if it reduces anxiety symptoms better than a placebo. Participants took the drug or a placebo daily, and researchers measured changes in anxiety levels using…

This study tested a new medicine called ENX-102 in 38 adults with generalized anxiety disorder (GAD). The goal was to see if it is safe and to find the best dose. Participants received either the drug or a placebo, and researchers monitored side effects and anxiety symptoms.

This early study tested an experimental drug called ENX-104 in 48 adults with major depressive disorder who also experience anhedonia (loss of interest or pleasure). The main goal was to check the drug's safety and how the body processes it. Researchers measured side effects and …

This early-stage study tested a single dose of the experimental drug ENX-104 in 10 healthy volunteers. Researchers used PET scans to see how much of the drug attached to certain brain receptors and checked for side effects. The goal was to gather safety and dosing information, no…

This early-stage study tested a single dose of an experimental drug called ENX-104 in 12 healthy adults. The goal was to see how the drug moves through the body when given as a liquid or a tablet, and whether a high-fat meal changes its absorption. No treatment for any disease wa…